Lantern Expands into Infusion Therapy Through Partnerships

 

The specialty care platform formerly known as Employer Direct Healthcare (EDH) has become Lantern, and the company announced its newest product offering – Infusion Care.

Lantern is also expanding its in-house clinical team to further build on its reputation for quality, naming former Teladoc Chief Quality Officer Dr. Jason Tibbels as Chief Medical Officer, along with several other key additions.

Through partnerships with leading infusion therapy providers across the country, Lantern Infusion Care gives members nationwide access to top-tier facilities within driving distance that offer more focused nurse attention, as well as at-home, 1:1 care when clinically appropriate.

By negotiating prices at the individual drug level and contracting across a range of site of care alternatives, Lantern and its partners can save employers upwards of 50% compared to what they typically pay while delivering care safely.

Lantern has facilitated more than 60,000 care journeys, including nearly 40,000 in the past two years. The company is the specialty care platform of choice for hundreds of the nation’s largest private and public sector employers, including Hyatt Hotels, 7-Eleven, and the State of Florida. Lantern is on track to add nearly 2 million more members by the end of the year.

By curating a Network of Excellence comprised of the nation’s top specialists for surgery, cancer care, infusions and more, Lantern delivers excellent care with significant cost savings to employers and their workforces. Lantern also pairs members with a dedicated care team, including Care Advocates and nurses, for the entirety of their care journey, helping them get back to good health, back to their families and back to work.

With convenient access to specialists nationwide, Lantern means quality care is within driving distance for most. Lantern is trusted by the nation’s largest employers to deliver care to more than 6 million members across the country.

Employer Direct Healthcare (EDH) announced a $92 million secondary investment in December 2023 from global software investor Insight Partners, bringing the company’s valuation to $1 billion. EDH’s existing institutional investors, Serent Capital, Redmile Group and Dundon Capital, will maintain their ownership interest in the business.

Also in 2023, Employer Direct Healthcare (EDH), whose SurgeryPlus® solution is the leading high performance specialty network for surgical care nationwide, and Sword Health, the first and only end-to-end platform to predict, prevent and treat pain, announced a new, highly integrated partnership that will deliver a complete solution to musculoskeletal care, from conservative care to surgical care for those who need it.

As part of this partnership, Sword introduced a solution specifically to support cancer patients during and after treatment, which is exclusively launching with EDH. The new Sword solution focuses on recovering mobility and strength, aiming to improve function and quality of life, and alleviate psychological distress for those patients.